Aviva PLC Hutchmed (China) LTD Transaction History

Aviva PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.63 - $15.52 $18,123 - $32,592	2,100 Added 4.62%	47,600 $422,000
Q2 2022 Aug 04, 2022	BUY	$8.59 - $20.77 $37,796 - $91,388	4,400 Added 10.71%	45,500 $575,000
Q1 2022 May 13, 2022	BUY	$15.52 - $35.65 $7,760 - $17,825	500 Added 1.23%	41,100 $778,000
Q4 2021 Feb 10, 2022	BUY	$28.89 - $35.33 $268,677 - $328,569	9,300 Added 29.71%	40,600 $1.42 Million
Q3 2021 Nov 12, 2021	BUY	$35.66 - $42.94 $299,544 - $360,696	8,400 Added 36.68%	31,300 $1.14 Million
Q1 2021 May 13, 2021	SELL	$27.01 - $36.8 $24,309 - $33,120	-900 Reduced 3.78%	22,900 $647,000
Q4 2020 Feb 10, 2021	BUY	$27.51 - $34.36 $19,257 - $24,052	700 Added 3.03%	23,800 $762,000
Q3 2020 Nov 12, 2020	SELL	$25.8 - $34.61 $25,800 - $34,610	-1,000 Reduced 4.15%	23,100 $746,000
Q2 2020 Aug 13, 2020	BUY	$17.65 - $28.05 $58,244 - $92,565	3,300 Added 15.87%	24,100 $665,000
Q1 2020 May 14, 2020	SELL	$15.19 - $29.51 $12,152 - $23,608	-800 Reduced 3.7%	20,800 $371,000
Q4 2019 Feb 10, 2020	BUY	$17.17 - $25.95 $66,963 - $101,205	3,900 Added 22.03%	21,600 $542,000
Q3 2019 Nov 12, 2019	BUY	$17.84 - $22.69 $24,976 - $31,766	1,400 Added 8.59%	17,700 $316,000
Q2 2019 Jul 30, 2019	BUY	$22.0 - $31.78 $15,400 - $22,246	700 Added 4.49%	16,300 $359,000
Q1 2019 May 14, 2019	BUY	$21.27 - $30.58 $74,445 - $107,030	3,500 Added 28.93%	15,600 $477,000
Q4 2018 Feb 12, 2019	BUY	$23.09 - $37.69 $279,389 - $456,049	12,100 New	12,100 $279,000

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.